AU2020396214B2 - Fusion of site-specific recombinases for efficient and specific genome editing - Google Patents
Fusion of site-specific recombinases for efficient and specific genome editingInfo
- Publication number
- AU2020396214B2 AU2020396214B2 AU2020396214A AU2020396214A AU2020396214B2 AU 2020396214 B2 AU2020396214 B2 AU 2020396214B2 AU 2020396214 A AU2020396214 A AU 2020396214A AU 2020396214 A AU2020396214 A AU 2020396214A AU 2020396214 B2 AU2020396214 B2 AU 2020396214B2
- Authority
- AU
- Australia
- Prior art keywords
- recombinase
- seq
- sequence
- site
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19214152.1A EP3831939A1 (en) | 2019-12-06 | 2019-12-06 | Fusion of site-specific recombinases for efficient and specific genome editing |
| EP19214152.1 | 2019-12-06 | ||
| PCT/EP2020/084489 WO2021110846A1 (en) | 2019-12-06 | 2020-12-03 | Fusion of site-specific recombinases for efficient and specific genome editing |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2020396214A1 AU2020396214A1 (en) | 2022-06-16 |
| AU2020396214B2 true AU2020396214B2 (en) | 2025-10-30 |
Family
ID=68808195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2020396214A Active AU2020396214B2 (en) | 2019-12-06 | 2020-12-03 | Fusion of site-specific recombinases for efficient and specific genome editing |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250243473A1 (https=) |
| EP (2) | EP3831939A1 (https=) |
| JP (1) | JP7702149B2 (https=) |
| CN (1) | CN115427558A (https=) |
| AU (1) | AU2020396214B2 (https=) |
| CA (1) | CA3163359A1 (https=) |
| MX (1) | MX2022006799A (https=) |
| WO (1) | WO2021110846A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3638776T3 (fi) | 2017-06-14 | 2025-12-09 | Univ Dresden Tech | Menetelmiä ja välineitä genomien geneettiseen muokkaamiseen hyödyntäen suunnittelu-DNA:ta rekombinoivia entsyymejä |
| EP4433584A1 (en) * | 2021-11-15 | 2024-09-25 | Technische Universität Dresden | Site-specific recombinases for efficient and specific genome editing |
| US20250145973A1 (en) * | 2023-10-16 | 2025-05-08 | Technische Universität Dresden Körperschaft Des Öffentlichen Rechts | Conditioned dna modifying enzyme comprising heterologous dna binding domain |
| WO2026022363A1 (en) | 2024-07-25 | 2026-01-29 | Technische Universität Dresden Körperschaft Des Öffentlichen Rechts | Modifying nucleic acid sequences having asymmetric target sites |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999025840A1 (en) * | 1997-11-18 | 1999-05-27 | Pioneer Hi-Bred International, Inc. | A novel method for the integration of foreign dna into eukaryoticgenomes |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981830A (en) | 1997-05-30 | 1999-11-09 | Schering Aktiengesellschaft | Knockout mice and their progeny with a disrupted hepsin gene |
| GB0029375D0 (en) * | 2000-12-01 | 2001-01-17 | Total Fina Elf | Substrate linked directed evolution (slide) |
| US20060014264A1 (en) * | 2004-07-13 | 2006-01-19 | Stowers Institute For Medical Research | Cre/lox system with lox sites having an extended spacer region |
| EP1942192A1 (en) | 2007-01-08 | 2008-07-09 | Heinrich-Pette-Institut für experimentelle Virologie und Immunologie | Use of a tailored recombinase for the treatment of retroviral infections |
| EP2576798B1 (en) | 2010-05-27 | 2016-04-27 | Heinrich-Pette-Institut Leibniz-Institut für experimentelle Virologie-Stiftung bürgerlichen Rechts - | Tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains |
| CN111254500B (zh) * | 2012-12-10 | 2024-01-23 | 分析生物科学有限公司 | 靶向基因组分析的方法 |
| EP2993229A1 (en) * | 2014-09-02 | 2016-03-09 | Heinrich-Pette-Institut Leibniz-Institut für experimentelle Virologie-Stiftung bürgerlichen Rechts - | Well-tolerated and highly specific tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains |
| US10017832B2 (en) * | 2015-08-25 | 2018-07-10 | Washington University | Compositions and methods for site specific recombination at asymmetric sites |
| FI3638776T3 (fi) | 2017-06-14 | 2025-12-09 | Univ Dresden Tech | Menetelmiä ja välineitä genomien geneettiseen muokkaamiseen hyödyntäen suunnittelu-DNA:ta rekombinoivia entsyymejä |
| KR20250133994A (ko) * | 2018-05-09 | 2025-09-09 | 케로스 테라퓨틱스, 인크. | 액티빈 수용체 유형 iia 변이체 및 그의 사용 방법 |
-
2019
- 2019-12-06 EP EP19214152.1A patent/EP3831939A1/en not_active Withdrawn
-
2020
- 2020-12-03 WO PCT/EP2020/084489 patent/WO2021110846A1/en not_active Ceased
- 2020-12-03 CA CA3163359A patent/CA3163359A1/en active Pending
- 2020-12-03 AU AU2020396214A patent/AU2020396214B2/en active Active
- 2020-12-03 CN CN202080095838.7A patent/CN115427558A/zh active Pending
- 2020-12-03 MX MX2022006799A patent/MX2022006799A/es unknown
- 2020-12-03 US US17/780,136 patent/US20250243473A1/en active Pending
- 2020-12-03 EP EP20816214.9A patent/EP4069834A1/en active Pending
- 2020-12-03 JP JP2022533406A patent/JP7702149B2/ja active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999025840A1 (en) * | 1997-11-18 | 1999-05-27 | Pioneer Hi-Bred International, Inc. | A novel method for the integration of foreign dna into eukaryoticgenomes |
Also Published As
| Publication number | Publication date |
|---|---|
| US20250243473A1 (en) | 2025-07-31 |
| WO2021110846A1 (en) | 2021-06-10 |
| CA3163359A1 (en) | 2021-06-10 |
| AU2020396214A1 (en) | 2022-06-16 |
| MX2022006799A (es) | 2022-09-07 |
| EP4069834A1 (en) | 2022-10-12 |
| CN115427558A (zh) | 2022-12-02 |
| JP7702149B2 (ja) | 2025-07-03 |
| JP2023504826A (ja) | 2023-02-07 |
| EP3831939A1 (en) | 2021-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2020396214B2 (en) | Fusion of site-specific recombinases for efficient and specific genome editing | |
| US11634463B2 (en) | Methods and compositions for treating hemophilia | |
| AU2017339511B2 (en) | Inducible caspases and methods for use | |
| EP2627665B1 (en) | Methods and compositions for treating hemophilia B | |
| EP3673053A1 (en) | Improved transposase polypeptide and uses thereof | |
| JP2022025081A (ja) | 血友病aの治療に有用な操作されたヌクレアーゼ | |
| US20230183713A1 (en) | Site-specific recombinases for efficient and specific genome editing | |
| US20240115739A1 (en) | Synthetic cas12a for enhanced multiplex gene control and editing | |
| US20090217400A1 (en) | Enzymes, cells and methods for site specific recombination at asymmetric sites | |
| SG11202108454RA (en) | Non-human animals comprising a humanized coagulation factor 12 locus | |
| CN108138147A (zh) | 含Fc蛋白的表达 | |
| US7135324B2 (en) | Viral recombinases, related articles, and methods of use thereof | |
| US7534874B2 (en) | Gene involved in V(D)J recombination and/or DNA repair | |
| JP2024527252A (ja) | 発現の増加した組み換えfviiiバリアントをコードするウイルスベクターを用いた、血友病aの遺伝子療法 | |
| HK1226756A1 (en) | Methods and compositions for treating hemophilia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |